newsWith vaccination programmes fighting to recover after the pandemic fuelled…
15 August 2022 | By Hannah Balfour (European Pharmaceutical Review)
With vaccination programmes fighting to recover after the pandemic fuelled the “largest backslide” in three decades, GSK says manufacturing challenges will leave a shortage of rotavirus vaccines.